Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Surgery Through the Mouth Safe and Effective

By HospiMedica International staff writers
Posted on 10 Oct 2012
Transoral robotic surgery (TORS) for supraglottic laryngectomy is an efficient way to remove tumors of the throat and larynx, according to a new study.

Researchers at the Ohio State University Comprehensive Cancer Center (Columbus, OH, USA) conducted a preliminary study that examined the outcomes of 13 head and neck cancer patients with laryngeal cancer who underwent TORS supraglottic laryngectomy. More...
The preliminary study is part of a larger prospective study involving 126 patients who underwent TORS between 2008 and 2011 to investigate the efficiency, safety, and functional outcomes of the procedure.

The results showed that negative surgical margins were achieved in all patients, and the average robotic operative time and estimated blood loss were 25.3 minutes and 15.4 mL, respectively. No surgical complications were encountered, and 11 of the 13 patients could accept an oral diet within 24 hours. Two patients (15.4%) received adjuvant radiation therapy based on pathology. The study was published ahead of print on August 21, 2012, in Head and Neck.

“The transoral robotic technique means shorter surgery, less time under anesthesia, a lower risk of complications and shorter hospital stays for these patients,” said lead author clinical associate professor of otolaryngology Enver Ozer, MD. “It also means no external surgical incisions for the patient and better 3-D visualization of the tumor for the surgeon.”

TORS is a group of minimally invasive robotic surgery techniques that enable surgeons to remove benign and malignant tumors of the mouth and throat. Designed to avoid incisions for primary site resection, TORS is performed through the patient's mouth and provides access to the small and often difficult-to-reach areas of the mouth and throat, resulting in virtually scarless head and neck surgery.

Related Links:

Ohio State University Comprehensive Cancer Center




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.